4 ms·
Is this a PR piece paid for by Novartis, the makers of Canakinumab? Wikipedia says the drug costs $8k/week and the initial study showed no survival benefit. T
by mleonhard 8y ago
Is this a PR piece paid for by Novartis, the makers of Canakinumab? Wikipedia says the drug costs $8k/week and the initial study showed no survival benefit. Then "further analysis" showed a big benefit. Something seems off.
https://en.wikipedia.org/wiki/Canakinumab https://en.wikipedia.org/wiki/Canakinumab
- zwkrt 8y agoInflammation can also be heavily reduced for "free" with a lifestyle change though, so I'm not exactly buying it.
- taneq 8y agoYeah but who's going to do that?
- frankzinger 8y agoNo, the article isn't about this drug at all. It gets mentioned at the beginning, mostly. The rest talks about biology. The main takewaways for me, after having read it in its entirety, were: * exercise regularly * don't overeat * ensure you're getting enough omega-3 (EDA and DHA, from fish/fish oil/algae) and arachidonic acid (beef/chicken/eggs)